major histocompatibility complex (MHC) haplotypes (21). Functional T-cell epitopes, as determined by LBT, were strongly associated with a concomitant antibody response, and genetic restriction was observed. Only one MVE virus peptide, peptide 6 (amino acids [aa] 230 to 251), predicted to contain two Th-cell epitopes and located in the R2 region of the E glycoprotein, showed reciprocal Th-cell reactivity with MVE virus and elicited antibody that would bind to virus. Only one other published study of flaviviruses has analyzed the predicted T-cell epitopes on the E proteins of JE, West Nile (WN), and the DEN serotype viruses (17). However, only three synthetic peptides, two of which were overlapping, were preliminarily investigated. T-cell analyses of synthetic peptides to other viruses have correlated the association between T-and B-cell responses (13, 25), the proliferative T-cell response (7, 10), or the antibody response (9, 28) 
previously evaluated in various strains of mice for both the induction of antibody and the in vitro proliferation of peptide-primed T-helper (Th) cells. MVE peptide 6 (amino acids 230 to 251) elicited reciprocal Th-and B-cell reactivity with native MVE virus after primary inoculation of C57BV6 mice. In this study, we prepared overlapping subunit peptides of MVE peptide 6 and evaluated their immunogenicity. Analysis of these peptides delineated at least two B-cell epitopes that induced antibody reactive with MVE and other Japanese encephalitis serocomplex viruses. This antibody at low titer neutralized MVE virus. Genetic restriction of the antibody response to various T-cell elements within peptide 6 was observed in C3H, BALB/c, C57BIJ6, and B10 congenic mice. One element demonstrable after primary immunization, located in the carboxy terminus, associated only with major histocompatibiity complex class II lAb and lAbIEk glycoproteins. Functional stimulation with the peptides in association with LAkIEk and IAdIEd molecules was observed only after in vivo secondary stimulation. Peptide 6-1 (amino acids 230 to 241) was nonimmunogenic but could be recognized by Th cells from peptide 6-immunized mice. Further association of peptide 6 with the IAkIEk and LIdEEd subregions was demonstrated by the finding that T cells from MVE peptide 6-inoculated C3H and BALB/c mice primed for an antibody response to MVE virus. These results suggest that the peptide 6 sequence, which is relatively conserved among a number of flaviviruses, should be given consideration when synthetic immunogens for vaccine purposes are designed.
The efficacy of viral vaccines is often measured by the presence of protective or neutralizing antibodies. An absolute requirement for antibody synthesis is the induction of T-helper (Th) cells to linear regions of viral proteins that are cognately linked within the context of the virion to B-cell epitopes. The cellular requirements for the humoral immune response have recently been reviewed in detail (38) . For flaviviruses, protection against infection is often mediated by neutralizing (NT) antibody to critical B-cell determinants present on the envelope (E) glycoprotein (14, 29) . Since dengue (DEN) and Japanese encephalitis (JE) viruses currently cause the most human disease (3, 11) , the development of an effective vaccine is of considerable importance.
Studies to evaluate the potential of synthetic peptides as possible flavivirus vaccine immunogens have been undertaken in our laboratory (30, 31 Viruses and antisera. MVE (Ord River) virus was propagated and purified as previously described (21) . WN (Eg 101), St. Louis encephalitis (SLE) (MSI-7), JE (Nakayama and SA-14), yellow fever (YF) (17D), and DEN 2 (JAM) were the other flaviviruses and strains used. Polyclonal hyperimmune ascitic fluids (HIAF) prepared against these viruses were obtained from the Arbovirus Diseases Branch of this laboratory. Antipeptide antisera were evaluated individually. Serum specimens with comparable antibody titers corresponding to their respective peptides were pooled (2 to 20 per group) for further analysis.
Peptide synthesis and immunization. Peptides were synthesized on an Applied Biosystems 430A automated peptide synthesizer by using t-butyloxycarbonyl chemistry and were cleaved from the resin with hydrofluoric acid by Multiple Peptide Systems. Peptides were analyzed for coupling efficiency (>98%) and purity as previously described (30) . The immunization protocol with MVE virus or with peptides in Freund's incomplete adjuvant in mice has been described in detail (21) .
T-cell epitope analyses. Peptide 6 was analyzed for putative T-cell epitopes by using two algorithms: Rothbard's motif (polar residue or glycine followed by two or three hydrophobic residues and then a polar residue) in association with alpha-helix formation (32) , and AMPHI, a computer program based on amphipathic helical characteristics of peptide molecules (19) . In the AMPHI program, the Fauchere-Pliska hydrophobicity scales of amino acids were used, the block length of 11 was selected, and the amphipathic score threshold was set at 4 (8) .
Th-cell proliferation assay. Th-cell proliferation was performed, using procedures described previously, on splenic T cells (chromatographed on nylon wool) from mice immunized with peptides or MVE virus (21, 22 described (2) . The NT assay using a constant amount of virus (20 to 50 PFU) and various serum dilutions was performed in Vero cells with MVE, SLE, and JE viruses. The procedure was similar to one described previously (23) .
RESULTS
Synthetic peptides. We previously found that C57BL/6 (H-2") mice immunized with peptide 6 (aa 230 to 251) elicited T cells and antibody that recognized MVE virus (21) . To further analyze the T-and B-cell epitopes, subunit peptides were prepared. The amino acid sequences of peptide 6 and the subunit peptides, as well as the locations of predicted Th-cell epitopes, are shown in Table 1 . The strategy used for subunit peptide synthesis was to separate the epitopes to ascertain functional characteristics. Peptide 6-1 (aa 230 to 241) contains only the Rothbard epitope (aa 237 to 241); peptide 6-2 (aa 239 to 251) splits the Rothbard epitope but defines the entire AMPHI-predicted segment. Finally, peptide 6-3 (aa 237 to 251) contains the region defining both epitopes but lacks the 7 aa at the amino terminus of peptide 6.
Antibody response in three strains of mice after primary and secondary inoculation with peptides. Inoculation of mice representing three different genetic backgrounds and MHC haplotypes with peptide 6 or its subunit peptides showed strain differences in antibody response to the homologous peptide ( Table 2) . Peptide 6 elicited a strong primary antibody response in C57BIV6 but not C3H or BALB/c mice. This result is similar to our previous observations except for the lower percentage of C3H responding mice (21) . Peptides 6-2 and 6-3 induced a good antibody response but only in C57BL/6 mice; all mice were nonresponsive to peptide 6-1. Nonresponder mice were given a second inoculation with homologous peptide; nearly all of the peptide 6-inoculated C3H and BALB/c mice strongly seroconverted, indicating that the mice had been primed. C3H and BALB/c mice that received a second inoculation with the subunit peptides remained unresponsive except for one BALB/c mouse in the peptide 6-2 group.
Reactivity of anti-peptide 6 sera with the subunit peptides. When seropositive specimens from the three strains of mice inoculated with peptide 6 were assayed in ELISA on peptide 6 and the subunit peptides, sera from C57BL/6 mice were strongly reactive with all four peptides (Table 3) . Mouse strain differences were apparent in sera from peptide 6-immune C3H mice, which were strongly reactive with peptides 6-2 and 6-3 but not peptide 6-1. In contrast, sera from BALB/c mice were reactive with peptide 6-1, but peptide 6-2 was not or was poorly recognized in four of five mice. Interestingly, peptide 6-3, which is different from peptide 6-2 by just two additional residues at the amino terminus, restored or enhanced antibody recognition in four of five mice. Although not shown in Table 3 , sera from the small 6 , since both peptides 6-2 and 6-3 elicited a Th-cell proliferative response (Table 4 ). In contrast, T cells from the aminoterminal peptide 6-1-immunized mice did not respond to homologous peptide in the LBT. These LBT results correlated with the C57BL/6 antibody response to these peptides in the same strain (Table 2) .
To determine the linear sequence in peptide 6 which is recognized by C57BL/6 B cells, sera pooled from animals immunized with each peptide were assayed in ELISA on all of the peptides and also on MVE virus (Table 4 ). Peptide 6-1 did not elicit an antibody response but contained a B-cell (Fig. 1B) . Sera from the peptide 6-immune B10 congenic mice, when tested in ELISA, recognized all of the subunit peptides (20) . This pattern was similar to the reactivity pattern of peptide 6 antisera from C57BL/6 mice (Table 3) .
After inoculation of C57BL/6 and B10 congenic mice with peptides 6-1 and 6-2, antibody was found just to peptide 6-2 and only from IAb (C57BV/6) and lAbIEk [BlO.A(5R)] mice ( Fig. 2A and C Secondary inoculation of peptide 6 low-responder mice with subunit peptides. When peptide 6-immunized but nonresponding B10 congenic mice were given a secondary inoculation with peptide 6-1, high-titered antibody (log10 geometric mean of >2.6) to peptide 6 was found in 5 of 10 TAkIEk animals ( Table 6 ). Four of the positive sera were reactive with peptides 6-2 and 6-3, and two of these sera recognized peptide 6-1. It is of interest that the peptide 6-1-induced antibody from animal 3 in the B1O.A(2R) group was reactive only with peptide 6. Just one of five of IAdIEd mice seroconverted following peptide 6-1 inoculation. However, peptide 6-1 induced a strong antibody response in four of four low-responding peptide 6-inoculated BALB/c (kIAdIEd) mice (Table 7 ). Peptide 6-1 inoculation of C3H (IA IEk) peptide 6-nonresponders elicited antibody in three of four mice from each group (Table 7) . Seroconversion in BALB/c mice was associated with higher levels of antibody to peptide 6 than to subunit peptides. Also, peptide 6-immune sera from the C3H mice did not recognize peptide 6-1, similar to what was observed earlier (Table 3) .
Peptide 6-related antigenic reactivity and biologic activity with various flaviviruses. The flavivirus antibody responses to peptides 6 and 6-3 were analyzed by using pooled antisera from high-responding C57BL/6 (H-2b) mice ( (21, 30) .
In this study, we show that when the same three strains of days, and all specimens had titers of < 1.7 in ELISA on peptide 6. Mice were bled on day 14 following secondary inoculation with peptide 6-1.
in LBT (22) . The antibody elicited by BALB/c and C3H mice to peptide 6 was reactive in ELISA with MVE virus (20) . 251) were not immunogenic by themselves; however, in peptide 6-primed mice, peptide 6-1 was able to associate with IAkIEk (BlO and C3H backgrounds) and IAdIEd (BALB/c background). Peptide 6-2 was seen by the same Ta glycoproteins on the C3H and BALB/c backgrounds. Therefore, the presence of the amino 7 to 9 or carboxy 10 aa or both restores immunogenicity to peptides 6-1 and 6-2 in IAkIEk and IAdIEd mice.
The immunological mechanism of the differential antibody induction seen in our study may be related to differences in the type of antigen-presenting cell (APC) used for the primary and secondary immune responses. Unanue (36) has suggested that the macrophage is the main APC in the murine primary immune response, while memory B cells are important as APC in a secondary response (5) . Alternatively, the various T-cell epitopes in peptide 6 may represent distinct T-cell priming elements. These epitopes may be related to the subpopulations of Th cells first described by Mosmann et al. (27) for murine T-cell clones. The lack of correlation of in vitro lymphoblastogenesis with the strong antibody response after secondary inoculation of IAkIEk and IAdIEd mice with peptide 6 may indicate (i) that nylon wool removed a Th-cell subset necessary for blastogenesis or (ii) that the frequency of memory Th-cell precursors was too low to be expanded in vitro. Tada et al. (35) showed that Th cells with Th2 characteristics bound to nylon wool, whereas Thl cells did not. Also, the in vitro T-cell assay may have lacked critical factors essential for blastogenesis that were present in the immunological microenvironment of the mouse (37) .
The subunit peptides also identified multiple B-cell epitopes within peptide 6. Peptide 6 antisera from C57BL/6 mice and MVE virus HIAF from NIH outbred Swiss mice both bound to peptide 6-1 in ELISA, but antisera to peptides 6-2 and 6-3 did not, indicating that at least two virus B-cell epitopes were present on peptide 6. One epitope mapped to the amino terminus, and another mapped to the carboxyterminal region. Therefore, peptide 6 is able to induce help for B-cell epitopes that are spatially separated. This effect was more precisely defined with the amino and carboxyterminal peptides 6-1 and 6-2 in peptide 6-primed mice. Both induced B-cell responses to at least two spatially separated B-cell epitopes. These are important observations, because it has been shown that the orientation of the Th-cell epitopes within peptides relative to the location of B-cell epitopes is important in terms of inducing antibody (4, 6, 24) .
More evidence for multiple B-cell epitopes was provided by the observation that peptide 6-immunized C3H mice lacked antibody only to peptide (Table 3 ). This finding indicated that Th-cell epitopes are not present in aa 230 to 241 in C3H mice as a result of differences in Ia antigens; alternatively, the absence of antibody may reflect a lack of recognition at the level of the B-cell repertoire. The latter view is indicated, since congenic B10 IA IEk mice produced antibody to peptide 6-1. Peptide 6 appeared to contain additional B-cell epitopes not seen on the subunit peptides by IAkIEk mice secondarily inoculated with peptides 6-1 and 6-2, since antibody levels were at least fourfold greater to peptide 6 in comparison with the subunit peptides in seven of eight of animals that responded.
The Th-cell epitopes on peptide 6 are biologically relevant in terms of vaccine potential, since they will associate with a variety of MHC types, and peptide-induced Th cells recognize native virus in vivo. This latter observation with synthetic immunogens to rabies virus (7), human T-cell lymphotropic virus (16) , and hepatitis B virus (26) has been associated with an enhanced antibody response to B-cell epitopes present on the challenge virus. This may be important for flaviviruses, since the dominant epitopes that induce NT antibody appear to be conformational and not linear (14) . Furthermore, the biologic relevance of peptide 6 Th-cell epitopes among the more medically important flaviviruses of the JE serocomplex was seen when peptide 6 Th cells from C57BL/6 mice recognized both SLE and JE viruses in LBT (1) . This result correlates with a high degree of homology in the sequence defining peptide 6 among JE serocomplex viruses (30) . The possibility that this region of the E glyco-protein is an important Th-cell-inducing immunogenic domain in other flaviviruses was suggested from an observation that a homolog of peptide 6 from DEN 2 virus has Th-cell activity (20) .
Antibody to MVE peptide 6 was antigenically reactive with JE complex viruses, but surprisingly, the peptide 6 B-cell epitopes were cryptic on infected cells. Antibody to peptide 6 had low-level NT activity with MVE virus. Cosynthesis of MVE peptide 6 with other JE complex virus B-cell epitopes more potent in inducing NT activity may be a feasible approach to the construction of potentially protective immunogens.
It may be possible to fine-tune the construction of flavivirus synthetic peptides for vaccine purposes with particular application to the DEN virus hemorrhagic fever/shock syndrome-related diseases (12) . Since B cells are the primary APC type involved in a secondary immune response and could therefore play a role in the immune enhancement phenomenon, the types of B-cell epitopes included in any vaccine must be carefully evaluated experimentally (5) . Another important consideration hypothesized by Kurane et al. (15) is that CD4+ cells secreting interferon exacerbate the pathogenesis of DEN hemorrhagic fever/shock syndrome; therefore, it is intriguing to consider the possibility of including in a prospective DEN synthetic vaccine T-cell epitopes that would induce only Th2 cells, which are capable of providing help to B cells but do not secrete interferon or participate in delayed-type hypersensitivity. This may be feasible since various immunogens will induce one or the other subpopulations of Th cells (33, 34) . In addition, a synthetic peptide to Leishmania sp. was shown to preferentially activate Th2 cells (18) .
